News
Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press Release
See all News
Sergey Axenovich
Director, RussiaSergey joined Burrill Merchant Banking in 2007. Before joining Burrill & Company, Sergey managed the cancer drug discovery program and associated corporate collaborations at PPD. He began his research career at Genome Therapeutics. Subsequently, he received his MBA from the University of California, Berkeley Haas School of Business. Sergey has a Ph.D. in Molecular Genetics from the University of Illinois, Chicago and an undergraduate degree in Molecular Biology from Moscow University.